Objective: Vascular responsiveness to vasoconstrictors is known to be attenuated in haemorrhagic shock. In this study we assessed the temporal development and the underlying mechanisms of haemorrhage-induced vascular hyporeactivity to pressor agents. Methods: In phenobarbital-anaesthetised rats hypotension was induced by graded haemorrhage (8 ml blood total). Sham-manipulated rats served as hyporesponsiveness. In contrast, the nitric oxide (NO) synthase inhibitor N -nitro-L-arginine methyl ester (10 mg kg ), as investigated 3 h post haemorrhage, restored the systemic pressor responses to angiotensin II and phenylephrine as well as the mesenteric constrictor responses to phenylephrine to normal level and diminished the mesenteric hyporesponsiveness to angiotensin II. Glibenclamide (20 21 1 mg kg ), an inhibitor of ATP-sensitive K channels given 180 min post haemorrhage, partially reversed haemorrhage-induced hypotension but did not modify angiotensin II hyporesponsiveness. Conclusion: Systemic pressor responsiveness and mesenteric arterial reactivity to endogenous and exogenous angiotensin II is selectively impaired at an early stage of haemorrhagic hypotension. This 1 phenomenon partially involves NO and is not related to ATP-sensitive K channels.
Introduction
aemia [4] , thermal injury [5] or haemorrhage [6] . Especially after haemorrhage, the ability of the organism to Reduced sensitivity to vasoconstrictor agents has been maintain blood pressure and organ perfusion is limited by known for a long time to be associated with hypotensive a progressive loss of responsiveness of the vasculature to states, as observed in pregnancy [1] , portal hypertension the compensatory release of vasoconstrictors, predominant-8 [2] or diabetes mellitus [3] , and shock, due to endotoxly catecholamines, angiotensin II and [Arg ]vasopressin. As a result, blood pressure further declines and becomes refractory to volume substitution (decompensatory phase) G Abbreviations: BF, blood flow; L-NAME, N -nitro-L-arginine methyl which irreversibly leads to death. the tissue is not a primary factor in triggering hyporespon-2.3. Experimental protocol and study groups siveness [7] . The potent vasodilator autacoid nitric oxide (NO) has been identified as a major mediator of vascular After preparation the rats were allowed to equilibrate hyporesponsiveness to adrenoceptor activation in haemoruntil haemodynamic parameters became stable (30-40 rhage [8] . However, the impact of NO on other pressor min). Haemorrhagic hypotension was induced by slow systems such as the renin-angiotensin axis has not yet withdrawal from a side-arm of the carotid cannula of 5 ml, been investigated. Moreover, it is unknown, whether and 30 min later, 3 ml of blood which corresponds to about hyporesponsiveness simultaneously and equally affects 25% of the total blood volume of the rats [10] . Shamseveral vasopressor systems. manipulated animals were included in all study groups as Therefore, it was the aim of the current study to controls. Animals that died before completion of the investigate the time course of the development of vascular experimental protocol were excluded from analysis. The hyporesponsiveness to various pressor agents, and the study was subdivided in five parts involving separate underlying mechanisms, in an in vivo model of moderate groups of rats. haemorrhagic hypotension in anaesthetised rats. We re-
The first part of the study investigated the effect of corded mean arterial pressure (MAP) and blood flow haemorrhagic hypotension on haemodynamic parameters 21 through the superior mesenteric artery, which was chosen and responsiveness to angiotensin II (10 pmol kg ) or 21 because it is involved in the regulation of systemic blood phenylephrine (10 nmol kg ), injected as i.v. bolus in a 21 pressure and is of crucial importance in the pathophysiolvolume of 0.33 ml kg . These doses of the vasoconstricogy of shock.
tors were used since they were about half maximally effective. Responsiveness to either angiotensin II or phenylephrine was determined immediately before and 2. Methods after the induction of haemorrhage every 30 min for 150 min.
Animal preparation
In the second part dose-response curves were constructed with increasing doses of either angiotensin II All experiments of this study were approved by the The third part assessed the involvement of cyclooxyrats were placed on a heated table, to maintain rectal genase products in the haemodynamic alterations due to temperature at 378C, and fitted with a tracheal cannula, to haemorrhage. To this end the rats were pretreated 30 min facilitate spontaneous respiration. Blood pressure was 21 before haemorrhage i.p. with vehicle (1 ml kg ) or measured via a cannula in the right carotid artery and 21 indomethacin at a dose (10 mg kg ) that has been shown recorded with a pressure transducer (ISOTEC; HSE, to effectively inhibit cyclooxygenase activity [11] . ResponMarch-Hugstetten, Germany). A second cannula was siveness to angiotensin II was determined immediately placed in the left jugular vein for the i.v. administration of before and after the induction of haemorrhage every 30 drugs. For blood flow measurements the superior mesenmin for 150 min. teric artery was exposed by midline laparotomy, isolated
The fourth part investigated the role of NO and ATPover a length of 5 mm, and special care was taken to 1 sensitive K channels in altered cardiovascular responsiveremove any tissue adherent to the adventitia. ness in haemorrhagic hypotension. At 160 min after haemorrhage the rats were injected i.v. with the NO 2.2. Haemodynamic measurements
NAME), at a dose (10 mg kg ) that is maximally Blood flow, in absolute values of ml min , was meaeffective in increasing MAP [12] , or the inactive enantiosured by the ultrasonic transit time shift technique with the personal computer via an analogue-digital converter. mg kg ), an inhibitor of ATP-sensitive K channels, or MAP, heart rate and mesenteric vascular conductance its vehicle (100 ml dimethyl sulfoxide) were injected i. To obtain a concentration of 1 mg ml telmisartan, of telmisartan which has been shown to be the maximally the solution was made up to a final volume of 2 ml by effective dose in decreasing MAP [13] .
adding distilled water, the pH being adjusted to |9.5 with 1 M HCl. The blank vehicle was prepared in an analogous 2.4. Substances manner.
Phenobarbital was dissolved in saline at a concentration 2. (RBI; Vienna, Austria) was dissolved in dimethyl sulfoxide termined and responses expressed as relative changes from (10 mg in 100 ml).
baseline to standardise responsiveness and allow for
figures as measured before the injection of a vasoconstric- The NO synthase inhibitor N -nitro-L-arginine methyl ester (L-NAME, 10 mg kg , i.v.), the inhibitor of ATP-sensitive K channels, glibenclamide tor are not shown since they did not differ from the values The dose of 10 nmol kg phenylephrine, injected i.v. as 21 described during the time course experiments (Figs. 1 and bolus, was equally effective as 10 pmol kg of angioten-2A) and were unchanged during the construction of dosesin II in raising MAP and constricting the mesenteric response curves as compared with immediately after the artery (Fig. 2C) , however, systemic hyporesponsiveness to treatment period (Table 1) .
the a-adrenoceptor agonist occurred only 2 h post haemorResponses in mean arterial pressure were expressed as D rhage (Fig. 2C) . Furthermore, mesenteric constrictor remm Hg, while responses in mesenteric vascular conductsponses were, despite a tendency towards diminution in ance in % of baseline since in previous studies we have haemorrhaged rats, similar in both groups during the initial found that there was no correlation between mean arterial 150 min (Fig. 2C) . At 3 h post haemorrhage, however, also pressure at baseline and pressor responses when calculated mesenteric constrictor responses were found to be sigas D mm Hg whereas a close negative correlation was nificantly blunted (Fig. 3B) . observed when calculated as % changes. Conversely, %
The dose-response curves, which were recorded 3 h changes did not correlate with basal mesenteric vascular after the induction of haemorrhage, revealed that in conductance, but a positive correlation was apparent when haemorrhaged rats systemic and mesenteric responsiveness were compared with two way repeated measures analysis (1-100 pmol kg ) were attenuated by haemorrhage of variance [14] . Two-sided probability values of P ,0.05 (Fig. 3C ). Mesenteric hyporeactivity was most pronounced were regarded as significant.
for angiotensin II and least for AVP (Figs. 3A, slightly declined until the end of the experiments (Fig. 1) .
Pretreatment with indomethacin (10 mg kg ) had no Superior mesenteric blood flow closely followed the time haemodynamic effects in control rats as compared with its course of MAP changes ( Fig. 1) with, consequently, no vehicle (n56, data not shown). Indomethacin pretreatment, alterations in mesenteric VC (Fig. 1) . Heart rate initially however, significantly enhanced the initial hypotensive decreased after haemorrhage, rapidly recovered and tended reaction to haemorrhage while the sustained phase of to be elevated at 3 h (Fig. 1 ). All these haemodynamic hypotension was not significantly altered ( Fig. 2A) . In parameters were constant in control rats throughout the 3-h contrast, the initial bradycardia and reduction in mesenteric observation period (Fig. 1) . Survival rate at 3 h was about BF were not modified by indomethacin (n57, data not 90% in the control and 70% in the haemorrhaged group.
shown). The development of angiotensin II hyporeactivity At baseline (time 0 min) i.v. bolus injections of ansubsequent to haemorrhage was also not prevented by 21 giotensin II (10 pmol kg ) transiently increased MAP by indomethacin pretreatment (Fig. 2B ). 15-25 mm Hg (Fig. 2B) , reduced mesenteric BF to 55-75% (data not shown) and mesenteric VC to 40-60% (Fig.  2B) little variability over the next 3 h in control rats (Fig. 2B) . Administration of L-NAME (10 mg kg ) 30 min before In contrast, both systemic pressor and mesenteric vasoconor shortly (20-40 min) after blood shedding proved lethal 21 strictor responses to angiotensin II (10 pmol kg ) became in all animals (n58) within the first 1 h post haemorrhage. significantly reduced as early as 1 h after the induction of L-NAME was, however, well tolerated when given 160 haemorrhage (Fig. 2B) . min after haemorrhagic hypotension had been induced. L-NAME increased MAP and decreased mesenteric VC to angiotensin II (10 pmol kg ) (n56, data not shown). In a similar extent in hypotensive and control rats (Table 1) .
contrast, when injected into rats 150 min after haemorAt 20 min after L-NAME treatment (i.e. 3 h post rhage, glibenclamide significantly increased MAP (Table  haemorrhage) responsiveness to angiotensin II or 1) and mesenteric blood flow (n56, data not shown) phenylephrine was determined. L-NAME abolished the without changing mesenteric VC (Table 1 ). However, difference between hypotensive and control rats in sysglibenclamide was unable to correct the systemic and temic reactivity to either pressor drug over the whole mesenteric hyporesponsiveness to angiotensin II (10 21 dose-response range (Fig. 4) , although it need be menpmol kg ) which had developed after haemorrhage (Fig. tioned that pressor responses were generally depressed 5). after treatment with L-NAME. Moreover, L-NAME restored the mesenteric constrictor responses to phenylep-3.5. Effects of angiotensin AT receptor antagonism 1 hrine to the level seen in control animals (Fig. 4B ).
21
Although mesenteric hyporeactivity to angiotensin II perIntravenous injection of telmisartan (1 mg kg ) imsisted after L-NAME (Fig. 4A) , the difference between mediately caused hypotension and mesenteric vasodilatcontrol and hypotensive rats was diminished. Since D- ation as indicated by an increase in mesenteric VC both in 21 NAME (10 mg kg ) had no appreciable haemodynamic control and haemorrhaged rats (Table 1 ). When given 1 h effects and did not alter responsiveness to angiotensin II or after haemorrhage had been induced telmisartan (1 21 phenylephrine neither in control nor haemorrhaged rats mg kg ) caused death in all animals (n54) by instantly (n54, data not shown), the effect of L-NAME to improve reducing MAP below 30 mm Hg. At 150 min post the vascular reactivity after haemorrhage appears to be haemorrhage, however, all animals (n58) survived the specifically related to inhibition of NO synthesis.
administration of the AT receptor antagonist. While the 1 mesenteric dilator effect only tended to be attenuated, the 
Effects of inhibiting ATP-sensitive K channels
hypotensive response to telmisartan was significantly weaker in rats subjected to haemorrhage when compared
21
Glibenclamide (20 mg kg ), given i.p. to control rats, with control rats (Table 1) . Two out of eight shocked had no significant effect on MAP and mesenteric VC animals did not exhibit any haemodynamic response to (Table 1) sive reaction to telmisartan was closely related to MAP was only observed in animals that died before completion before the injection of the drug in shocked rats (r50.96, of the experimental protocol and usually began 10-20 min n58, P50.0002; linear regression analysis), but was prior to exitus (data not shown). The high survival rate of independent from MAP in control rats (r50.47, n58, not the animals and the lack of tachycardia and mesenteric significant).
vasoconstriction are indices for a moderate and probably reversible nature of the shock model applied here [15, 16] . Pressor and mesenteric constrictor responses to an-4. Discussion giotensin II were unchanged at 30 min but were blunted at 60 min after the induction of haemorrhage. In contrast, In the present study we found that in anaesthetised rats responsiveness to phenylephrine was maintained for at responsiveness to angiotensin II is selectively impaired at least 2 h, when systemic pressor responses to the aan early stage of haemorrhagic hypotension and that this adrenoceptor agonist decreased. At the end point of our hyporeactivity is in part mediated by nitric oxide, but does experiments (i.e. 3 h after haemorrhage) systemic pressor 1 not involve prostaglandins or ATP-sensitive K channels. responses to angiotensin II and phenylephrine, but not 8
Our data suggest that hyporeactivity to angiotensin II [Arg ]vasopressin, were reduced. Mesenteric hyporesponhampers circulatory adaptation to hypovolaemia and might siveness to any of these agents was manifest at 3 h post be an initial event in the development of decompensated haemorrhage and was most pronounced to angiotensin II 8 shock. It should be noted, though, that the present observawhile only marginal to [Arg ]vasopressin. To any of these tions were made in anaesthesia, which is known to alter pressor agents hyporeactivity was confined to low and cardiovascular responsiveness. moderate test doses but was absent at the highest doses Withdrawal of 8 ml of blood resulted in a marked applied, indicating preserved mechanical coupling of the hypotension and transient bradycardia which is a frequent receptors in smooth muscle. Moreover, the hypotensive reaction at a blood loss of 20-30% of total blood volume reaction to AT receptor antagonism was significantly 1 [15] . Mesenteric BF decreased in parallel while mesenteric attenuated in haemorrhaged rats. Telmisartan lowers mean vasoconstriction did not occur as indicated by unchanged arterial pressure by selectively antagonising angiotensin II VC. Mesenteric vasoconstriction of an appreciable extent on AT receptors [17] . Since the pressor and vasoconstric-1 also suggested by a 100% mortality rate after telmisartan administration shortly after bleeding. In contrast, MAP in indomethacin-and vehicle-treated rats did not differ two hour after haemorrhage and telmisartan was well tolerated when given at this time. From these data it might be inferred that angiotensin II plays an important role in the early compensatory phase but consecutively loses its pressor potency, and its supporting role on MAP is taken over by some other vasoactive substances such as vasopressin [21] . Cardiovascular hyporesponsiveness to angiotensin II was, however, not due to the release of vasodilator prostaglandins since its development was not modified by indomethacin pretreatment. Moreover, the lack of effect of indomethacin also suggests that AT receptor down-regu-1 lation or desensitisation by excess angiotensin II was not the underlying mechanism since inhibition of cyclooxygenase is known to prevent the renin / angiotensin response to haemorrhage [18] .
The potent vasodilator factor NO has been implicated in the pathogenesis of various shock forms, as induced by bacterial endotoxin, anaphylaxis, thermal injury and also haemorrhage, and has been blamed for causing vasodilatation, hyporesponsiveness to vasoconstrictors and transition to an irreversible stage [22, 23] . The role of NO was 1 also confirmed in the current experiments, as inhibition of Mesenteric constrictor responses, however, were left unaltered by L-NAME in control rats. In contrast, mesenteric responsiveness to phenylephrine, which had become tor responses to exogenous angiotensin II have been found blunted after haemorrhage, was restored to normal by to be diminished after haemorrhage, it may be not too L-NAME, while constrictor responses to angiotensin II speculative to relate the blunted hypotensive effect of the remained attenuated even after NO inhibition. These antagonist to a blunted vasoconstrictor effect of endogenobservations confirm earlier reports that hyporesponsiveous angiotensin II. This is remarkable, since extensive ness to adrenoceptor agonists after haemorrhage is merelease of angiotensin II is part of cardiovascular adaptadiated by NO [8] , but also demonstrate that additional, tion to hypovolaemia and haemorrhage [18] [19] [20] . The NO-independent factors are involved in hyporeactivity to significant correlation of MAP with the responsiveness to angiotensin II. exogenous and endogenous angiotensin II in haemor-AT receptors have been proposed to play a role in 2 rhaged, but not control, rats is tempting to speculate that various cardiovascular disorders, partly via release of the limited capacity of MAP to recover from haemorrhage vasodilator kinins and NO thereby opposing the action of might be related to hyporesponsiveness to angiotensin II.
AT receptors [24, 25] . The involvement of AT receptors 1 2 Pretreatment with indomethacin had per se no haemoin the current observations, however, appears unlikely, dynamic effect but enhanced the early hypotensive resince under normal conditions no or very little AT 2 sponse to haemorrhage. This effect was most probably due receptors are expressed in the adult splanchnic vasculature to blockade by cyclooxygenase inhibition of the renin [26, 27] and in a previous study we could not detect a response to haemorrhage which is known to involve the hypotensive or mesenteric dilator effect of angiotensin II local release of prostaglandins in the kidneys [18] and after AT receptor blockade [13] . On the other hand, de angiotensin II has become manifest.
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